{"id":22741,"date":"2024-02-19T14:40:31","date_gmt":"2024-02-19T13:40:31","guid":{"rendered":"https:\/\/ggba.swiss\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/"},"modified":"2024-02-19T14:45:07","modified_gmt":"2024-02-19T13:45:07","slug":"atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/","title":{"rendered":"Atinary et Takeda s\u2019unissent pour acc\u00e9l\u00e9rer le d\u00e9veloppement de m\u00e9dicaments"},"content":{"rendered":"\n<p><a href=\"https:\/\/atinary.com\/\">Atinary Technologies<\/a>, connue pour sa plateforme r\u00e9volutionnaire Self-Driving Labs (<a href=\"https:\/\/atinary.com\/solutions\/\">SDLabs<\/a>), est \u00e0 l&rsquo;avant-garde de l&rsquo;int\u00e9gration de l&rsquo;apprentissage machine (ML) dans les flux de travail de R&amp;D de diverses industries, y compris les produits pharmaceutiques. En adoptant la technologie SDLabs d&rsquo;Atinary, <a href=\"https:\/\/www.takeda.com\/\">Takeda<\/a> vise \u00e0 affiner ses processus de d\u00e9couverte et de d\u00e9veloppement de m\u00e9dicaments, en garantissant une approche plus rationalis\u00e9e qui pourrait r\u00e9duire consid\u00e9rablement le temps n\u00e9cessaire \u00e0 la mise sur le march\u00e9 de nouvelles th\u00e9rapies.<\/p>\n\n\n\n<p>Ce partenariat strat\u00e9gique devrait permettre de fusionner la technologie d&rsquo;IA de pointe d&rsquo;Atinary avec l&rsquo;expertise \u00e9tendue de Takeda en mati\u00e8re de recherche et de d\u00e9veloppement pharmaceutique (R&amp;D), promettant ainsi d&rsquo;acc\u00e9l\u00e9rer la d\u00e9couverte de m\u00e9dicaments et d&rsquo;am\u00e9liorer l&rsquo;efficacit\u00e9 du processus de d\u00e9veloppement de m\u00e9dicaments.<\/p>\n\n\n\n<p>Takeda, dont la riche histoire remonte \u00e0 2019 \u00e0 Neuch\u00e2tel, apr\u00e8s l&rsquo;acquisition de la soci\u00e9t\u00e9 britannique Shire, est un acteur majeur des soins de sant\u00e9 dans le monde. <a href=\"https:\/\/ggba.swiss\/fr\/takeda-va-investir-chf-200-millions-dans-son-site-de-neuchatel\/\">L&rsquo;investissement de la soci\u00e9t\u00e9 dans l&rsquo;expansion de ses capacit\u00e9s de production<\/a> et son d\u00e9vouement \u00e0 l&rsquo;innovation s&rsquo;alignent sur la mission d&rsquo;Atinary d&rsquo;acc\u00e9l\u00e9rer la d\u00e9couverte et le d\u00e9veloppement de mol\u00e9cules et de mat\u00e9riaux r\u00e9volutionnaires gr\u00e2ce \u00e0 sa plateforme ML robuste.<\/p>\n\n\n\n<p>La collaboration strat\u00e9gique entre Atinary et Takeda est une initiative historique qui combine les prouesses d&rsquo;Atinary en mati\u00e8re d&rsquo;IA, de science des donn\u00e9es, de robotique et d&rsquo;informatique en cloud avec l&rsquo;expertise profond\u00e9ment enracin\u00e9e de Takeda en mati\u00e8re de R&amp;D pharmaceutique. Ensemble, ils ont pour objectif de d\u00e9bloquer de nouvelles possibilit\u00e9s dans la d\u00e9couverte de m\u00e9dicaments, en faisant des progr\u00e8s vers le d\u00e9veloppement de traitements qui pourraient avoir un impact significatif sur la vie des patients dans le monde entier.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Atinary Technologies, sp\u00e9cialiste vaudois de l&rsquo;apprentissage automatique, s&rsquo;est associ\u00e9 \u00e0 Takeda, la plus grande entit\u00e9 pharmaceutique du Japon, pour faire avancer l&rsquo;innovation dans le domaine de la sant\u00e9.<\/p>\n","protected":false},"author":6,"featured_media":22738,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1179,1183,1180,1188,1171,1142],"class_list":["post-22741","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-artificial-intelligence-fr-2","tag-big-data-en-fr","tag-digital-health-fr-2","tag-healthcare-fr-2","tag-pharma-fr-2","tag-rd-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Atinary et Takeda d\u00e9marrent un partenariat strat\u00e9gique | GGBa<\/title>\n<meta name=\"description\" content=\"Atinary Technologies a d\u00e9marr\u00e9 un partenariat strat\u00e9gique avec Takeda pour faire avancer l&#039;innovation dans le domaine de la sant\u00e9.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atinary et Takeda d\u00e9marrent un partenariat strat\u00e9gique | GGBa\" \/>\n<meta property=\"og:description\" content=\"Atinary Technologies a d\u00e9marr\u00e9 un partenariat strat\u00e9gique avec Takeda pour faire avancer l&#039;innovation dans le domaine de la sant\u00e9.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-19T13:40:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-19T13:45:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2360\" \/>\n\t<meta property=\"og:image:height\" content=\"1622\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Atinary et Takeda s\u2019unissent pour acc\u00e9l\u00e9rer le d\u00e9veloppement de m\u00e9dicaments\",\"datePublished\":\"2024-02-19T13:40:31+00:00\",\"dateModified\":\"2024-02-19T13:45:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/\"},\"wordCount\":344,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg\",\"keywords\":[\"Artificial Intelligence\",\"Big Data\",\"Digital Health\",\"Healthcare\",\"Pharma\",\"R&amp;D\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/\",\"name\":\"Atinary et Takeda d\u00e9marrent un partenariat strat\u00e9gique | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg\",\"datePublished\":\"2024-02-19T13:40:31+00:00\",\"dateModified\":\"2024-02-19T13:45:07+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Atinary Technologies a d\u00e9marr\u00e9 un partenariat strat\u00e9gique avec Takeda pour faire avancer l'innovation dans le domaine de la sant\u00e9.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg\",\"width\":2360,\"height\":1622,\"caption\":\"Cette alliance entre Atinary et Takeda est un exemple de la fa\u00e7on dont la technologie et les soins de sant\u00e9 peuvent se rejoindre pour cr\u00e9er des solutions innovantes qui r\u00e9pondent aux d\u00e9fis urgents du d\u00e9veloppement de m\u00e9dicaments.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Atinary et Takeda s\u2019unissent pour acc\u00e9l\u00e9rer le d\u00e9veloppement de m\u00e9dicaments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Atinary et Takeda d\u00e9marrent un partenariat strat\u00e9gique | GGBa","description":"Atinary Technologies a d\u00e9marr\u00e9 un partenariat strat\u00e9gique avec Takeda pour faire avancer l'innovation dans le domaine de la sant\u00e9.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/","og_locale":"fr_FR","og_type":"article","og_title":"Atinary et Takeda d\u00e9marrent un partenariat strat\u00e9gique | GGBa","og_description":"Atinary Technologies a d\u00e9marr\u00e9 un partenariat strat\u00e9gique avec Takeda pour faire avancer l'innovation dans le domaine de la sant\u00e9.","og_url":"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-02-19T13:40:31+00:00","article_modified_time":"2024-02-19T13:45:07+00:00","og_image":[{"width":2360,"height":1622,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Atinary et Takeda s\u2019unissent pour acc\u00e9l\u00e9rer le d\u00e9veloppement de m\u00e9dicaments","datePublished":"2024-02-19T13:40:31+00:00","dateModified":"2024-02-19T13:45:07+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/"},"wordCount":344,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg","keywords":["Artificial Intelligence","Big Data","Digital Health","Healthcare","Pharma","R&amp;D"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/","url":"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/","name":"Atinary et Takeda d\u00e9marrent un partenariat strat\u00e9gique | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg","datePublished":"2024-02-19T13:40:31+00:00","dateModified":"2024-02-19T13:45:07+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Atinary Technologies a d\u00e9marr\u00e9 un partenariat strat\u00e9gique avec Takeda pour faire avancer l'innovation dans le domaine de la sant\u00e9.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg","width":2360,"height":1622,"caption":"Cette alliance entre Atinary et Takeda est un exemple de la fa\u00e7on dont la technologie et les soins de sant\u00e9 peuvent se rejoindre pour cr\u00e9er des solutions innovantes qui r\u00e9pondent aux d\u00e9fis urgents du d\u00e9veloppement de m\u00e9dicaments."},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/atinary-et-takeda-sunissent-pour-accelerer-le-developpement-de-medicaments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Atinary et Takeda s\u2019unissent pour acc\u00e9l\u00e9rer le d\u00e9veloppement de m\u00e9dicaments"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/22741","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=22741"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/22741\/revisions"}],"predecessor-version":[{"id":22743,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/22741\/revisions\/22743"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/22738"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=22741"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=22741"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=22741"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}